Abstract
Purpose of Review
Patients with congenital heart disease (CHD) are living longer due to advances in cardiovascular medicine. We sought to review the physiology and evaluation of these CHD patients who demonstrate the emerging need for combined heart and liver transplantation.
Recent Findings
The principal population affected by failing cardiohepatic physiology are those with single-ventricle physiology palliated to Fontan. Patients are evaluated by a multidisciplinary team including transplant cardiology and hepatology to determine the degree of liver damage and necessity of combined heart and liver transplantation. While still only performed at a limited number of centers, early data suggest good graft and patient survival.
Summary
Combined heart and liver transplantation is warranted in a specific subset of patients with CHD. En bloc heart and liver transplantation may offer benefits including reduction in ischemia times. As experience increases, additional guidelines to help direct care for these patients will be warranted.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Daniels CJ, Bradley EA, Landzberg MJ, Aboulhosn J, Beekman RH III, Book W, et al. Fontan-associated liver disease: proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC. J Am Coll Cardiol. 2017;70:3173–94. https://doi.org/10.1016/j.jacc.2017.10.045.
Gilboa SM, Devine OJ, Kucik JE, Oster ME, Riehle-Colarusso T, Nembhard WN, et al. Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010. Circulation. 2016;134:101–9. https://doi.org/10.1161/CIRCULATIONAHA.115.019307.
Hill AL, Maeda K, Bonham CA, Concepcion W. Pediatric combined heart-liver transplantation performed en bloc: a single-center experience. Pediatr Transplant. 2012;16:392–7. https://doi.org/10.1111/j.1399-3046.2012.01695.x.
• Vaikunth SS, et al. Short-term outcomes of en bloc combined heart and liver transplantation in the failing Fontan. Clin Transpl. 2019;33(e13540). https://doi.org/10.1111/ctr.13540This study discusses the evaluation and outcomes of both adult and pediatric patient undergoing en bloc combined heart and liver transplantion for failing Fontan physiology.
Norozi K, Wessel A, Alpers V, Arnhold JO, Geyer S, Zoege M, et al. Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am J Cardiol. 2006;97:1238–43. https://doi.org/10.1016/j.amjcard.2005.10.065.
Diamond T, Ovchinsky N. Fontan-associated liver disease: monitoring progression of liver fibrosis. Clin Liver Dis (Hoboken). 2018;11:1–5. https://doi.org/10.1002/cld.681.
Goldberg DJ, et al. Hepatic fibrosis is universal following fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study. J Am Heart Assoc. 2017;6. https://doi.org/10.1161/JAHA.116.004809.
Jacob KA, Hjortnaes J, Kranenburg G, de Heer F, Kluin J. Mortality after cardiac surgery in patients with liver cirrhosis classified by the Child-Pugh score. Interact Cardiovasc Thorac Surg. 2015;20:520–30. https://doi.org/10.1093/icvts/ivu438.
Greenway SC, Crossland DS, Hudson M, Martin SR, Myers RP, Prieur T, et al. Fontan-associated liver disease: implications for heart transplantation. J Heart Lung Transplant. 2016;35:26–33. https://doi.org/10.1016/j.healun.2015.10.015.
• Romero R. Liver in congenital heart disease: implications of the fontan procedure for pediatric and adult liver specialists. Clin Liver Dis (Hoboken). 2013;2:210–4. https://doi.org/10.1002/cld.241This article discusses Fontan procedure, physiology, and the downstream effect on liver disease.
Lightsey JM, Rockey DC. Current concepts in ischemic hepatitis. Curr Opin Gastroenterol. 2017;33:158–63. https://doi.org/10.1097/MOG.0000000000000355.
Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F. Heart failure and liver disease: cardiohepatic interactions. JACC Heart Fail. 2019;7:87–97. https://doi.org/10.1016/j.jchf.2018.10.007.
Gordon-Walker TT, Bove K, Veldtman G. Fontan-associated liver disease: a review. J Cardiol. 2019;74:223–32. https://doi.org/10.1016/j.jjcc.2019.02.016.
McCormick AD, Schumacher KR. Transplantation of the failing Fontan. Transl Pediatr. 2019;8:290–301. https://doi.org/10.21037/tp.2019.06.03.
Alsaied T, Bokma JP, Engel ME, Kuijpers JM, Hanke SP, Zuhlke L, et al. Factors associated with long-term mortality after Fontan procedures: a systematic review. Heart. 2017;103:104–10. https://doi.org/10.1136/heartjnl-2016-310108.
Schumacher KR, Kindel SJ. Considerations for advanced heart failure consultation in Fontan patients: guidance for primary cardiologists, <http://www.actionlearningnetwork.org> (2020).
Surrey LF, Russo P, Rychik J, Goldberg DJ, Dodds K, O'Byrne ML, et al. Prevalence and characterization of fibrosis in surveillance liver biopsies of patients with Fontan circulation. Hum Pathol. 2016;57:106–15. https://doi.org/10.1016/j.humpath.2016.07.006.
Farr M, Mitchell J, Lippel M, Kato TS, Jin Z, Ippolito P, et al. Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction. J Heart Lung Transplant. 2015;34:873–82. https://doi.org/10.1016/j.healun.2014.12.009.
Grimm JC, Magruder JT, Do N, Spinner JA, Dungan SP, Kilic A, et al. Modified model for end-stage liver disease eXcluding INR (MELD-XI) score predicts early death after pediatric heart transplantation. Ann Thorac Surg. 2016;101:730–5. https://doi.org/10.1016/j.athoracsur.2015.06.063.
Poterucha JT, Johnson JN, Qureshi MY, O’Leary PW, Kamath PS, Lennon RJ, et al. Magnetic resonance elastography: a novel technique for the detection of hepatic fibrosis and hepatocellular carcinoma after the Fontan operation. Mayo Clin Proc. 2015;90:882–94. https://doi.org/10.1016/j.mayocp.2015.04.020.
Ebel NH, et al. Hepatic venous pressure gradient measurements in children: correlation with hepatic histology and clinical indicators of portal hypertension. J Pediatr Gastroenterol Nutr. 2019;68:788–92. https://doi.org/10.1097/MPG.0000000000002327.
Hsia TY, Khambadkone S, Deanfield JE, Taylor JFN, Migliavacca F, de Leval MR. Subdiaphragmatic venous hemodynamics in the Fontan circulation. J Thorac Cardiovasc Surg. 2001;121:436–47. https://doi.org/10.1067/mtc.2001.112527.
Wong TW, Gandhi MJ, Daly RC, Kushwaha SS, Pereira NL, Rosen CB, et al. Liver allograft provides immunoprotection for the cardiac allograft in combined heart-liver transplantation. Am J Transplant. 2016;16:3522–31. https://doi.org/10.1111/ajt.13870.
Gugenheim J, et al. Specific absorption of lymphocytotoxic alloantibodies by the liver in inbred rats. Transplantation. 1990;50:309–13. https://doi.org/10.1097/00007890-199008000-00027.
• D'Souza BA, et al. Single-center outcomes of combined heart and liver transplantation in the failing Fontan. Clin Transpl. 2017;31. https://doi.org/10.1111/ctr.12892This article evaluates outcomes in adult patients who underwent combined heart and liver transplantation for failing Fontan physiology.
Hollander SA, Reinhartz O, Maeda K, Hurwitz M, N. Rosenthal D, Bernstein D. Intermediate-term outcomes after combined heart-liver transplantation in children with a univentricular heart. J Heart Lung Transplant. 2013;32:368–70. https://doi.org/10.1016/j.healun.2012.11.023.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Liver Transplantation
Rights and permissions
About this article
Cite this article
Than, P.A., Brubaker, A.L., Ebel, N.H. et al. The Emerging Need for Combined Heart and Liver Transplantation in Congenital Heart Disease. Curr Transpl Rep 7, 180–186 (2020). https://doi.org/10.1007/s40472-020-00286-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40472-020-00286-y